Search Within

Elisa De Stanchina

  1. "Wouter Karthaus"
Formats
  1. Journal Article (5)
  2. Meeting Abstract (2)
Groups
  1. Department of Medicine (7)
  2. GSK Faculty (7)
  3. Human Oncology and Pathogenesis Program (7)
  4. Sloan Kettering Institute Postdocs (7)
  5. Center for Hematologic Malignancies (6)
  6. Executive Committee, Center for Hematologic Malignancies (6)

More Groups

People
  1. Wouter Karthaus (7)
  2. Charles Sawyers (6)
  3. Samir Zaidi (4)
  4. Alvaro Quintanal Villalonga (3)
  5. Charles Rudin (3)
  6. Juan Qiu (3)

More People

Years
  1. 2024 (2)
  2. 2023 (2)
  3. 2020 (1)
  4. 2017 (1)
  5. 2015 (1)
Publications
  1. Annals of Oncology (1)
  2. Cancer Cell (1)
  3. Cancer Research (1)
  4. Nature Cancer (1)
  5. Science (1)
  6. Science Translational Medicine (1)

More Publications

Publishers
  1. American Association for the Advancement of Science (2)
  2. American Association for Cancer Research (1)
  3. Cell Press (1)
  4. Nature Research (1)
  5. Oxford University Press (1)
  6. Springer Nature (1)

Results (7)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The neuroendocrine transition in prostate cancer is dynamic and dependent on ASCL1
    Journal Article

    Romero, R.; Chu, T.; González Robles, T. J.; Smith, P.; Xie, Y.; Kaur, H.; Yoder, S.; Zhao, H.; Mao, C.; Kang, W.; more...
    Nature Cancer (2024)

    Fulltext@MSK | Save
  • CDC7 inhibition impairs neuroendocrine transformation in lung and prostate tumors through MYC degradation
    Journal Article

    Quintanal-Villalonga, A.; Kawasaki, K.; Redin, E.; Uddin, F.; Rakhade, S.; Durani, V.; Sabet, A.; Shafer, M.; Karthaus, W. R.; Zaidi, S.; more...
    Signal Transduction and Targeted Therapy (2024)

    Fulltext@MSK | Save
  • CDC7 inhibition constrains lineage plasticity and prevents resistance and neuroendocrine transformation in the lung and prostate
    Meeting Abstract

    Quintanal-Villalonga, Á.; Zaidi, S.; Karthaus, W. R.; Zhan, Y. A.; Shafer, M.; Qiu, J.; de Stanchina, E.; Haffner, M. C.; Sawyers, C. L.; Rudin, C. M.
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Exportin 1 inhibition prevents neuroendocrine transformation through SOX2 down-regulation in lung and prostate cancers
    Journal Article

    Quintanal-Villalonga, A.; Durani, V.; Sabet, A.; Redin, E.; Kawasaki, K.; Shafer, M.; Karthaus, W. R.; Zaidi, S.; Zhan, Y. A.; Manoj, P.; more...
    Science Translational Medicine (2023)

    Fulltext@MSK | Save
  • Tumor microenvironment-derived NRG1 promotes antiandrogen resistance in prostate cancer
    Journal Article

    Zhang, Z.; Karthaus, W. R.; Lee, Y. S.; Gao, V. R.; Wu, C.; Russo, J. W.; Liu, M.; Mota, J. M.; Abida, W.; Linton, E.; more...
    Cancer Cell (2020)

    Fulltext@MSK | Save
  • SOX2 promotes lineage plasticity and antiandrogen resistance in TP53-and RB1-deficient prostate cancer
    Journal Article

    Mu, P.; Zhang, Z.; Benelli, M.; Karthaus, W. R.; Hoover, E.; Chen, C. C.; Wongvipat, J.; Ku, S. Y.; Gao, D.; Cao, Z.; more...
    Science (2017)

    Fulltext@MSK | Save
  • TP53 and RB1 alterations promote reprogramming and antiandrogen resistance in advanced prostate cancer
    Meeting Abstract

    Mu, P.; Cao, Z.; Hoover, E.; Wongvipat, J.; Huang, C. H.; Karthaus, W.; Abida, W.; De Stanchina, E.; Sawyers, C.
    Cancer Research (2015)

    Fulltext@MSK | Save